HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
7th Edition of Cardiology World Conference
October 08-10, 2026 | Tokyo, Japan
Cardiovascular Translational Research
Cardiovascular Translational Research
According to Translational research in Cardiology, it is the method of using advanced procedures to promote their importance in fields of cardiovascular disease, diagnosis and treatment to speed up scientific discovery into patient and future community benefit.It addresses critical medical needs. In applied sciences, it is specifically designed to improve health outcomes. Types of Translational Research:
- T1 research
- T2 research
- T3 research
- T4 research
Committee Members
Yochai Birnbaum
Baylor College of Medicine, United States
Robert J Chilton
University of Texas Health Science Center San Antonio, United States
Yong Xiao Wang
Albany Medical Center, United States Cardio 2026 Speakers
Mekhman N Mamedov
National Research Center for Therapy and Preventive Medicine, Russian Federation
Sergey Suchkov
Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Sekib Sokolovic
ASA Hospital Sarajevo, Bosnia and Herzegowina
Syed Raza
Awali Hospital, BahrainSubmit your abstract Today
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, Professor in Medicine & Immunology, Director for Center for Biodesign of N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation